89728-15-4

Usage

Uses

Used in Pharmaceutical Industry:
2,3-Diamino-4,6-dimethyl-5-bromopyridine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of biologically active compounds. Its presence in the molecular structure can enhance the pharmacological properties of drugs, making it a valuable component in drug discovery and design.
Used in Agrochemical Industry:
In the agrochemical sector, 2,3-Diamino-4,6-dimethyl-5-bromopyridine is utilized as a building block in the creation of agrochemicals, such as pesticides and herbicides. Its incorporation can improve the effectiveness of these chemicals in controlling pests and weeds, thereby contributing to increased crop yields and agricultural productivity.
Used in Materials Science:
2,3-Diamino-4,6-dimethyl-5-bromopyridine is employed as a component in the development of new materials due to its unique chemical properties. Its versatility allows it to be integrated into various material systems, potentially enhancing their performance characteristics in areas such as conductivity, stability, and reactivity.
Used in Nanotechnology:
2,3-Diamino-4,6-dimethyl-5-bromopyridine also finds application in nanotechnology, where its unique properties can be harnessed to create novel nanostructures and materials with specific functions. This can include the development of nanoparticles with targeted drug delivery capabilities or the creation of materials with enhanced sensing or catalytic properties.
Overall, 2,3-Diamino-4,6-dimethyl-5-bromopyridine is a multifaceted chemical with broad applications across different industries, underscoring its importance in the synthesis of various products and the advancement of scientific research.

InChI:InChI=1S/C7H10BrN3/c1-3-5(8)4(2)11-7(10)6(3)9/h9H2,1-2H3,(H2,10,11)

Upstream product

• 98950-02-8 (2-amino-5-bromo-4,6-dimethyl-[3]pyridyl)-carbamic acid methyl ester 
• 5407-87-4 2-Amino-4,6-dimethylpyridine 
• 89856-44-0 2-amino-5-bromo-4,6-dimethylpyridine 
• 89791-76-4 2-amino-3-nitro-4,6-dimethyl-5-bromo-pyridine 

Downstream Products

• 92336-10-2 6-bromo-5,7-dimethyl-1⁽³⁾H-imidazo[4,5-b]pyridine 
• 121655-34-3 6-bromo-5,7-dimethyl-1H-[1,2,3]triazolo[4,5-b]pyridine 
• 114163-51-8 5,7-dimethyl-1H-[1,2,3]triazolo[4,5-b]pyridine 
• 116599-55-4 5,7-dimethyl-1(3)H-imidazo[4,5-b]pyridine 

Relevant academic research and scientific papers

First demonstration of positive allosteric-like modulation at the human wild type translocator protein (TSPO)

We show that changing the number and position of nitrogen atoms in the heteroatomic core of a pyrazolopyrimidine acetamide is sufficient to induce complex binding to wild type human TSPO. Only compounds with this complex binding profile lacked intrinsic effect on glioblastoma proliferation but positively modulated the antiproliferative effects of a synthetic TSPO ligand. To the best of our knowledge this is the first demonstration of allosteric-like interaction at the wild type human TSPO.

N-pyridinyl(alkyl)polyhalogenobenzamides acting as TNF-α production inhibitors

A series of N-pyridinyl(methyl)fluorobenzamides issued from 2,4-dimethyl-6-aminopyridine and 3-aminomethylpyridine were synthesized and evaluated as inhibitors of TNF-α production. Although less active than the corresponding phthalimides, several pentaflu

PYRIDYL IMIDAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF

Substituted pyridyl imidazole derivatives of formula (I) inhibit effectively the action of angiotensin II and have a superior anti-hypertensive activity. STR1

Diaminopyridine compounds and methods of use

The present invention relates to compositions and method for inhibiting nonenzymatic cross-linking (protein aging) which contain diaminopyridines and derivates thereof. Accordingly, a composition is disclosed which comprises an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.